Irene Venturelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irene Venturelli has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aida Meto
Department of Dentistry, Faculty of Dental Sciences, University of Aldent, 1007 Tirana, Albania
1 shared publication - Alessandra Odorici
Laboratory of Microbiology and Virology, School of Doctorate in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
1 shared publication - Bruna Colombari
Laboratory of Microbiology and Virology, Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
1 shared publication - Elena Giberti
Azienda Unita' Sanitaria Locale Di Modena, Modena, Italy, Italy
1 shared publication - Elisabetta Blasi
Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy
1 shared publication - Geminiano Bandiera
Emergency Department, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy, Italy
1 shared publication
Latest Publications
- Open Access
- 16 July 2026
- Published by MDPI AG in Preprints.org
Monocyte Distribution Width (MDW) as an Early Biomarker of Blood Culture Positivity and Clinically Significant Bloodstream Infection in Emergency Department: A Real-World Study
Background: Monocyte Distribution Width (MDW) is a hematological parameter automatically generated during routine blood count analysis and currently represents the only blood count-derived biomarker for early sepsis risk assessment in adult emergency department (ED) patients. Evidence regarding its ability to identify blood culture (BC) positivity and bloodstream infection (BSI) remains limited. This cohort study aimed to evaluate its diagnostic accuracy. Methods: Adult patients presenting to the ED of a tertiary hospital with suspected infection and BC request were evaluated. Between March 2022 and December 2024, MDW, C-reactive protein (CRP), and BC results were retrospectively collected from the laboratory information system. Samples were categorized as BC-negative or BC-positive and further stratified into microbiological categories. Diagnostic performance was assessed using ROC curve analysis and decision curve analysis (DCA). Analyses were performed both including and excluding CoNS. Results: A total of 2,748 samples were available. MDW values were significantly higher in BC-positive than in BC-negative samples (25.8±6.7 vs. 23.4±4.7) and were highest in Gram-negative infections (27.7±7.5). When CoNS were excluded, MDW achieved an AUC of 0.65 at the optimal cut-off of 24.5, showing a sensitivity of 58% and specificity of 66.2%. Rule-out thresholds of 17.7 and 18.7 achieved sensitivities of 95% and 92.9%, respectively, whereas rule-in thresholds of 29.4 and 32 achieved specificities of 90.0% and 95.2%. MDW consistently outperformed CRP and demonstrated positive clinical net benefit in DCA. The addition of CRP did not provide improvement in diagnostic accuracy (AUC 0.65). Conclusions: MDW is associated with BC positivity and clinically significant BSI and outperforms CRP in identifying patients with BC-positive in the ED supporting its integration into diagnostic stewardship strategies and early risk stratification pathways.
- 16 July 2026
- Published by MDPI AG in Preprints.org
Open AccessMonocyte Distribution Width (MDW) as an Early Biomarker of Blood Culture Positivity and Clinically Significant Bloodstream Infection in Emergency Department: A Real-World Study
Background: Monocyte Distribution Width (MDW) is a hematological parameter automatically generated during routine blood count analysis and currently represents the only blood count-derived biomarker for early sepsis risk assessment in adult emergency department (ED) patients. Evidence regarding its ability to identify blood culture (BC) positivity and bloodstream infection (BSI) remains limited. This cohort study aimed to evaluate its diagnostic accuracy. Methods: Adult patients presenting to the ED of a tertiary hospital with suspected infection and BC request were evaluated. Between March 2022 and December 2024, MDW, C-reactive protein (CRP), and BC results were retrospectively collected from the laboratory information system. Samples were categorized as BC-negative or BC-positive and further stratified into microbiological categories. Diagnostic performance was assessed using ROC curve analysis and decision curve analysis (DCA). Analyses were performed both including and excluding CoNS. Results: A total of 2,748 samples were available. MDW values were significantly higher in BC-positive than in BC-negative samples (25.8±6.7 vs. 23.4±4.7) and were highest in Gram-negative infections (27.7±7.5). When CoNS were excluded, MDW achieved an AUC of 0.65 at the optimal cut-off of 24.5, showing a sensitivity of 58% and specificity of 66.2%. Rule-out thresholds of 17.7 and 18.7 achieved sensitivities of 95% and 92.9%, respectively, whereas rule-in thresholds of 29.4 and 32 achieved specificities of 90.0% and 95.2%. MDW consistently outperformed CRP and demonstrated positive clinical net benefit in DCA. The addition of CRP did not provide improvement in diagnostic accuracy (AUC 0.65). Conclusions: MDW is associated with BC positivity and clinically significant BSI and outperforms CRP in identifying patients with BC-positive in the ED supporting its integration into diagnostic stewardship strategies and early risk stratification pathways.
- Open Access
- 30 June 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (13) , 8056
Novel Options to Counteract Oral Biofilm Formation: In Vitro Evidence
Biofilm production on biotic and abiotic surfaces is crucial in the pathogenesis of most infections, particularly those occurring in the oral cavity. Its prevention and/or control may greatly facilitate the management of patients with oral diseases. Here, the antibiofilm activity of a biomimetic hydroxyapatite and a natural compound, MicroRepair (MicroR) and pomegranate (PomeGr), respectively, was assessed. By luminescence/fluorescence-based assays, Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) were tested for biofilm production in the presence of MicroR and/or PomeGr. We found that both MicroR and PomeGr could affected biofilm production; however, the efficacy of the two, given alone or in combination, varied according to the microbial agent considered. These data open to clinical studies aimed at defining the most efficacious protocols to counteract oral biofilm-associated infections.
- 30 June 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (13) , 8056
Open AccessNovel Options to Counteract Oral Biofilm Formation: In Vitro Evidence
Biofilm production on biotic and abiotic surfaces is crucial in the pathogenesis of most infections, particularly those occurring in the oral cavity. Its prevention and/or control may greatly facilitate the management of patients with oral diseases. Here, the antibiofilm activity of a biomimetic hydroxyapatite and a natural compound, MicroRepair (MicroR) and pomegranate (PomeGr), respectively, was assessed. By luminescence/fluorescence-based assays, Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) were tested for biofilm production in the presence of MicroR and/or PomeGr. We found that both MicroR and PomeGr could affected biofilm production; however, the efficacy of the two, given alone or in combination, varied according to the microbial agent considered. These data open to clinical studies aimed at defining the most efficacious protocols to counteract oral biofilm-associated infections.